A phase II trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer.

@article{Yang2013API,
  title={A phase II trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer.},
  author={Lin Yang and Yan Song and Ai-ping Zhou and Qiong Qin and Yihebali Chi and Jing Huang and Jin-wan Wang},
  journal={Chinese medical journal},
  year={2013},
  volume={126 18},
  pages={3470-4}
}
BACKGROUND Palliative chemotherapy has been shown to have a survival benefit for patients with recurrent or metastatic gastric cancer. We conducted a Phase II trial to determine the efficacy and safety of S-1 plus oxaliplatin (SOX regimen) as first-line chemotherapy for patients with unresectable locally advanced or metastatic gastric cancer. METHODS… CONTINUE READING